Non-celiac wheat sensitivity (NCWS) is a newly described clinical entity characterized by symptoms, which can involve the gastrointestinal tract, the nervous system, the skin, and other organs. There is little data on the pathogenesis of NCWS and it is probable that different pathogenic mechanisms are involved in the different clinical manifestations of the disease. The only common denominator of NCWS " syndrome " is wheat consumption: the symptoms disappear on exclusion of wheat from the diet, and reappear on wheat consumption. The objective of this study was to review our prior data regarding NCWS and to review relevant medical literature regarding NCWS, with particular attention to the hypothesis that NCWS patients could suffer from non-immunoglobulin E (IgE)-mediated wheat allergy.
INTRODUCTION

The defi nition of NCWS
In the last 5 years since the publication of the very stimulating article by Elena Verd ù about patients with irritable bowel syndrome-like (IBS-like) symptoms who fully resolve their symptoms on gluten-free diet even though they do not fulfill the diagnostic criteria for celiac disease (CD) or wheat allergy ( 1 ) , there has been scientific interest in a possibly new clinical condition, which has been called a " fertile crescent for research " ( 2 ) . This condition was initially named " gluten sensitivity " ( 3, 4 ) , but subsequently the term " non-celiac gluten sensitivity " ( 5 ) was preferred to better distinguish it from CD. However, it is not known which components of wheat cause the symptoms in non-celiac gluten sensitivity patients, and because there is no definite proof that gluten is really the culprit ( 6 ), we prefer the term " non-celiac wheat sensitivity " (NCWS) ( 7 ) .
The spectrum of NCWS symptoms
Many gastrointestinal and extra-gastrointestinal symptoms have been attributed to NCWS. Table 1 summarizes the clinical symptoms reported in the literature and those which we have observed in our patients ( 4,7 -10 ) . Symptoms can aff ect both gastrointestinal and extra-gastrointestinal systems and it is probable that this list will change in the next few years, including new manifestations, but also excluding some of those now listed. For example, although there is general agreement that patients suff ering from NCWS can have neurological manifestations, it is unknown whether some psychiatric symptoms (i.e., depression) can be considered a direct consequence of wheat ingestion or are dependent on a patient ' s poor quality of life. Similarly, some patients have reported weight loss but it is not clear whether this is related to a malabsorption syndrome or self-limited diet because of fear of symptoms aft er meals. On the contrary, some patients report weight gain on a wheat-containing diet and a dramatic weight normalization aft er wheat exclusion from their diet. What is counterintuitive is that the patients subjectively report that their daily caloric intake remains identical or even higher. In these cases also, an accurate evaluation of the glycemic index of the foods consumed before and aft er the wheat-free diet should be mandatory, as a simple modifi cation in the insulin levels could be the basis of the body weight change. In general, it should be emphasized that such a large and heterogeneous list of manifestations very probably cannot have a single pathogenic mechanism. In this context, wheat ingestion could cause diff erent symptoms by diff erent mechanisms so NCWS cannot be considered a distinct clinical condition. In other words, NCWS cannot be considered " the sister " of CD; that is not the proper model, according to our analysis.
To minimize possible errors in the study of the NCWS, the study population needs to be specifi cally defi ned and carefully grouped according to the clinical presentation. Th at was done in patients with IBS diagnosed according to the Rome II criteria ( 7 ) . Th e results of that study and our previous clinical experience suggested to us that a portion of NCWS patients with IBS could be suff ering from non-immunoglobulin E (IgE)-mediated food hypersensitivity (FH). Th e aims of this study are: (a) to re-evaluate the results of the double-blind placebo-controlled (DBPC) food challenges in patients with IBS, underlining the results which could suggest an allergic pathogenesis; (b) perform a narrative review of the use of DBPC challenge, the role of serum immunoglobulin G (IgG) antibodies, and the basophil activation assay in food allergy, and the histology fi ndings in the food allergy diagnosis.
METHODS
All patients included in the previous study were prescribed a standard elimination diet with the exclusion of wheat, cow ' s milk (CM), eggs, tomato, and chocolate ( 7 ) . Patients self-reporting FH were asked to avoid ingestion and / or contact with the food(s) causing symptoms. Aft er 4 weeks on elimination diet, they underwent DBPC challenges. We performed the wheat challenge by administering a daily dose 13 g of fl our, equivalent to about 20 g of bread.
A total of 12 capsules daily were given, three times daily, away from meals. DBPC challenge for CM proteins was performed with an identical method, administering capsules containing casein, lactoalbumin, and lactoglobulin, at least 4 weeks before or aft er wheat challenge and when the patients were asymptomatic, on elimination diet. Xylose was used as placebo. Th e shape and size of the capsules were identical in each case. Further details have been previously published ( 7 ) . In this study, we re-evaluated the results of the DBPC challenges in the IBS patients included in a previous study ( 7 ) . Th e Fisher ' s test was used for frequency comparison; a P value < 0.05 was considered statistically signifi cant.
RESULTS
The DBPC wheat challenge in patients with IBS-like manifestations
About one-third of > 900 patients with IBS resolved their symptoms on elimination diet and relapsed into symptoms on DBPC wheat challenge ( 7 ). Table 2 summarizes the clinical and laboratory characteristics of the patients with NCWS and multiple food sensitivity included in that study ( 7 ) , which can suggest an allergic background; for comparison, patients with IBS not due to food sensitivity (i.e., not improved on elimination diet) were selected. A personal history of food allergy in the pediatric age, coexistent atopic diseases, positive serum anti-gliadin and anti-betalactoglobulin antibodies, positive cytofl uorimetric assay revealing in vitro basophil activation by food antigens, and presence of eosinophils in the intestinal mucosa biopsies, seem strong indicators of FH. Although demonstrating the existence of NCWS by means of the DBPC challenge method is probably the main result of that study, we believe it is of great interest to have revealed that 206 of the 276 patients suff ering from NCWS showed the same IBS-like symptoms on CM protein DBPC challenge. Furthermore, the majority of those same patients showed symptoms, on open challenge, with egg, chocolate, and other foods.
DISCUSSION AND NARRATIVE REVIEW OF THE LITERATURE
Th e evidence that the majority of NCWS patients included in our study also exhibited CM protein hypersensitivity ( 7 ), leads 
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choice is precisely because the AGA assay may help confi rm a suspicion of NCWS. Furthermore, it is of interest that Ruuskanen et al. ( 18 ) showed that HLA-DQ2 -positive or HLA-DQ8 -positive subjects who were tested positive for serum AGA had more severe gastrointestinal symptoms than the antibody-negative subjects. However, it must be emphasized that the positive predictive value of the AGA assay in NCWS diagnosis is very low, as it is also positive in 10 -14 % of patients with IBS who do not improve on elimination diet ( 7 ). In our hypothesis, the high levels of serum AGA, as the high levels of IgG anti-betalactoglobulin antibodies, could be an indicator of FH, but it must be emphasized that the data on this are very controversial. Burks et al. ( 19 ) examined antibody responses to milk proteins in patients with milk protein intolerance shown by oral challenge, and found no increase in IgG antibodies aft er positive challenge. Shek et al. ( 20 ) concluded that food-specifi c IgG or IgG4 do not add any information to the food allergy diagnostic workup, that is, milk-induced IgE-mediated and nonIgE-mediated disorders. In contrast, the literature suggests that food-specifi c IgG presence is a marker of food exposure and tolerance, as seen in those participating in oral immunotherapy studies ( 21 ) .
Based on the above-mentioned studies, it has been affi rmed that the inappropriate use of food-specifi c IgG assay might only increase the likelihood of false diagnoses, resulting in unnecessary dietary restrictions and decreased quality of life ( 22 ) . As a result of these serious and growing concerns, the Canadian Society of us to suggest that a great percentage of NCWS could be categorized as being aff ected by " multiple FH, " a condition, which is well known in the pediatric literature ( 11, 12 ) . In this regard, the fundamental role of the DBPC method must be stressed in the diagnosis of FH in patients with gastrointestinal manifestations. Defi nite proof of underlying immunological mechanisms is lacking for most gastrointestinal disorders due to food allergy, except for those mediated by food-specifi c IgE antibodies ( 13 ) . However, because most gastrointestinal food allergies are not mediated by IgE antibodies, alternative assays in the determination of eosinophil by-products in biopsy specimens or fecal samples have been investigated; no such tests with acceptable diagnostic accuracy have been found ( 13 ) .
Th e same considerations should apply to the diagnosis of NCWS. It has been clearly demonstrated that wheat can cause gastrointestinal symptoms in the context of FH and multiple FH. For example, utilizing the DBPC challenge method, we found that a subgroup of children with chronic constipation due to CM allergy ( 14 ) , which did not resolve on CM-free diet, were suff ering from wheat hypersensitivity also, and that in these patients the exclusion of wheat, egg, and other foods resolved the symptom ( 15 ) . Similar data subsequently reported that in adult patients with chronic constipation unresponsive to laxative treatment, CM-free and wheat-free diet were eff ective in treating the symptoms ( 16 ) .
Th e hypothesis that in a percentage of cases NCWS is a manifestation of non-IgE-mediated food allergy, is strengthened by the higher frequency of a history of food allergy in the pediatric age that we found in our cases (see Table 2 ). Although we used the Fisher ' s test instead of a multiple analysis and this could have determined a type 1 error, the high frequency of history of food allergy in the pediatric age in the adults suff ering from NCWS is an important datum, which we have observed in daily clinical practice. In this respect, Table 3 summarizes some questions that we regularly pose to adult patients with suspected NCWS or FH (i.e., self-reported wheat-intolerant patients). We are now evaluating the diagnostic accuracy of this questionnaire to propose a possible score. In any case, it is surely useful in daily practice to decide which patients have a higher probability of suff ering from NCWS and should be placed on an elimination diet, and whoever has a lower probability and should be directed to a " conventional " treatment for IBS.
Obviously, the response to the elimination diet and to the subsequent challenge justifi es or excludes a diagnosis of NCWS or multiple FH.
A diagnostic role for serum IgG in NCWS
Our data and the data of others showed that about 50 -60 % of NCWS patients had elevated serum values of IgG anti-gliadin antibodies (AGAs) ( 7, 8 ) . Although the use of these antibody assays in CD diagnosis is advised against ( 17 ) , according to this fi nding we think that when faced with a patient who has symptoms because of the consumption of gluten-containing foods, it is logical to test both anti-transglutaminase assay -the serum gold standard in reaching CD diagnosis -and anti-gliadin assay. Th is As controls we included a group of patients with IBS not due to food intolerance (from reference Carroccio et al. ( 7 )). The Fisher's test was used for frequency comparison; a P value < 0.05 was considered statistically signifi cant. Eosinophils were counted at a HPF (40 × ); the presence of > 4 eosinophils per HPF in the colon mucosa biopsy was considered " positive " . ( 24 ) have warned against the inappropriate measurement of food-specifi c IgG or IgG4 to suggest the presence of potential adverse food reactions. Recent guidelines emphasize that such testing has no role in the diagnosis of food allergy or intolerance ( 25 ) .
In strong opposition to the above mentioned studies and position papers, Zar et al. ( 26, 27 ) d emonstrated that food-specifi c IgG4 antibody-guided exclusion diet improves symptoms in IBS patients and is associated with rectal compliance improvement. Atkinson et al. ( 28 ) used a double blind, randomized, controlled, parallel design in which IBS patients were randomized to either a " true " diet or a " sham " diet control group, based on the presence / absence of food-specifi c IgG antibodies to a panel of 29 diff erent food antigens, which showed that food elimination based on IgG antibodies may be eff ective in reducing IBS symptoms. Our group also showed a very high diagnostic accuracy of IgG anti-betalactoglobulin assay in pediatric patients with IBS-like ( 29 ) or gastroesophageal refl ux disease ( 30 ) .
Th e assay of IgG for food antigens in the suspicion of multiple FH, including NCWS, should be discouraged and the elimination diet based on the results of these assays should not be advised. However, until a reliable serum marker of NCWS is found, serum IgG AGA could be helpful.
The usefulness of basophil activation assay in NCWS diagnosis
Th e basophil activation assay, or basophil activation test (BAT), is an in vitro assessment of allergic response that requires only a small quantity of whole blood and allows measurement of a functional response, beyond just the presence of IgE class antibody. Th e assay currently uses fl ow cytometry to detect upregulation, aft er antigen stimulation, of some activation markers (e.g., CD63 or CD203c) usually expressed on the cell surface, in order to identify activated basophils ( 31 ) .
BAT has been shown to be sensitive and specifi c for the diagnosis of IgE-mediated hypersensitivity reactions to pollens, hymenoptera venom, natural rubber latex allergy, and drugs ( 32 -34 ) . In regard to food allergy, it has been demonstrated that BAT could be more specifi c than skin PRICK test and / or food-specifi c IgE ( 35 ) , and it is a reliable tool for the diagnosis of CM allergy in pediatric patients, with sensitivity similar to routine diagnostic tests but with higher specifi city ( 36 ) .
However, there have been very few studies on the possible usefulness of BAT in patients with IBS-like symptoms and suspected NCWS or food-hypersensitivity. In this setting, we have previously shown confl icting data. In a prospective study, we evaluated the effi cacy of BAT in the diagnosis of multiple FH in IBS-like patients ( 37 ) . In this study, BAT diagnosed NCWS with 86 % sensitivity, 88 % specifi city, and 87 % accuracy. Th is diagnostic accuracy can be considered excellent in a fi eld that has no serologic marker to aid in the diagnosis. However, the commercial assay that we had used in the past changed methods, and since the year 2010 a new assay on whole blood replaced the old assay performed on separated leukocytes. Consequently, in our daily clinical practice we observed a fall in the accuracy of the assay; for this reason in a subsequent study we compared the " old " and the " new " BAT methods ( 38 ) . Our results showed that the new BAT CD63-based detection on whole blood samples is not useful in FH and NCWS diag nosis. Furthermore, data from Ciacci et al. do not confi rm the usefulness of BAT in NCWS diagnosis ( 39 ) .
In summary, BAT accuracy in NCWS diagnosis seems excessively infl uenced by a method that is not standardized and reproducible. Th e use of a commercial kit cannot be recommended, but in each center the results of a " home-made assay " could be compared with the results of DBPC wheat challenge to obtain an internal reference of BAT accuracy. Whatever is the real percentage of positive BAT in NCWS patients, the evidence of basophil cell activation aft er wheat in vitro challenge adds strength to the hypothesis of an allergic pathogenesis in a subgroup of NCWS. In patients with IBS-constipation: have you suffered from chronic constipation since infancy and the pediatric age?
Chronic constipation with poor response to laxative treatment, in the pediatric age, is often an unrecognized sign of food hypersensitivity.
Have you suffered (or are suffering) from allergic rhinitis or conjunctivitis or bronchial asthma or atopic dermatitis?
Previous history or coexistence of atopic diseases increase the probability of NCWS or multiple food hypersensitivity.
Did you suffer from umbilical erythema (presence of erythematous skin in the umbilical and periumbilical region, with or without secretion) in the pediatric age, or are you suffering from it now?
The skin in the umbilical area can be affected by localized dermatitis and may be a sign of food allergy.
Did you suffer from perianal erythema (presence of erythematous skin in the anal and perianal region) in the pediatric age, or are you suffering from it now?
The skin in the perianal area can be affected by localized dermatitis and may be a sign of food allergy.
DBPC, double-blind placebo-controlled; IBS, irritable bowel syndrome; MFH, multiple food hypersensitivity; NCWS, non-celiac wheat sensitivity. A positive response increases the probability of a correct diagnosis of NCWS or MFH.
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Marsh 1 histology in 33 of 78 (42 % ) cases. Our recent retrospective study ( 7 ) showed a duodenal mucosa IEL increase ( > 25 IEL / enterocytes) in 248 of 276 cases (90 % ). In our study ( 7 ) , as in that of Sapone et al. ( 44 ) , the entity of IEL infi ltration was intermediate between those observed in patients with CD and in controls with " functional " gastrointestinal disorders (dyspepsia or IBS). However, IEL infi ltration of the duodenal mucosa can be due to several causes ( 45 ), so it is not possible to consider this fi nding specifi c of wheat sensitivity. A more plausible histology marker of NCWS suggested by our experience is the mucosal eosinophil infi ltrate. Colon histology evaluation showed intraepithelial and lamina propria infi ltration of eosinophils in about two-thirds of cases and this fi nding was also frequently observed in the duodenum ( 7 ). We found > 4 intraepithelial eosinophils (at a high-power fi eld: 40 × ) in the colon mucosa in 174 of 276 (63 % ) NCWS patients; furthermore, the count of the duodenal intraepithelial eosinophils was signifi cantly higher in NCWS patients than in IBS controls ( 7 ) . In an experimental model, it has been shown that oral antigen can induce eosinophilic infl ammation in various segments of the gastrointestinal tract, including the esophagus, stomach, small intestine, and Peyer ' s patches ( 46 ) . It is known that both the mixed IgE-mediated and non-IgE-mediated diseases comprise distinct hypersensitivity disorders that are characterized by a pronounced eosinophil infi ltration of the gastrointestinal tract and have been referred to as eosinophil-associated gastrointestinal disorders ( 47 ) .
In several previous studies, we found that the eosinophil infiltrate in the intestinal mucosa characterized the patients suffering from chronic constipation due to food allergy ( 12, 13 ) . Similar histological data were reported in school-age children with rectal bleeding due to allergic procto-colitis ( 48 ) . It is also interesting that in 70 of 206 (35 % ) patients with NCWS and CM protein hypersensitivity, we found the presence of lymphoid hyperplasia in the colon mucosa ( 7 ) . This histology characteristic has been reported in adult patients ( 49 ) and children ( 50 ) with rectal bleeding due to food allergy. In clinical practice, the eosinophil infiltrate and / or the presence of lymphoid hyperplasia in the colon or duodenal mucosa cannot be considered an accurate diagnostic marker of NCWS. However, their presence could recommend an elimination diet; the clinical response to the diet and the subsequent DBPC challenge confirm the diagnosis.
Alternative and supplementary hypotheses
Although we have shown several aspects that could indicate an allergic condition at the basis of the functional bowel disease in NCWS patients, it is very probable that diff erent pathogenic mechanisms are responsible for IBS-like symptoms in diff erent subgroups of patients or even in the same patient.
First, some proteins in wheat are difficult to digest as the human intestine physiologically lacks the enzymes, which should cut the protein chains into single amino acids. Residual long peptides could have a role in causing functional digestive problems. Furthermore, it is becoming more difficult to
The association between NCWS and atopic diseases
In regard to a possible association between NCWS and atopic diseases, Massari et al. ( 40 ) found a very high frequency (29 % ) of duodenal mucosa lesions in patients with atopic diseases (asthma, rhinitis, or contact dermatitis); all patients were negative for CD-specifi c serum antibodies (endomysial antibodies) and showed gastrointestinal problems, which disappeared on gluten-free diet and the authors concluded that NCWS commonly occurs in allergic patients. Although some limitations of the study must be noted, that is, patients with intestinal villi atrophy were included -the frequency of the association reported by the authors is surprising.
Th e other side of this relationship was shown in our recent study ( 7 ) . We found that 73 of 206 patients suff ering from NCWS associated with CM protein hypersensitivity showed coexistent atopic diseases: a frequency signifi cantly higher than that observed in patients suff ering from IBS. In general, the relationship between FH and atopic manifestations, although investigated in patient-based studies, has been scarcely evaluated in the general population.
According to a recent study of the Centers for Disease Control and Prevention, children with food allergy are about 2 -4 times more susceptible to develop further clinical manifestations, such as respiratory allergies (3.6-fold), asthma (4.0-fold), and atopic dermatitis (2.4-fold), compared with children without food allergy ( 41 ) . Several studies reported the co-occurrence of other allergic conditions in adult patients with food allergy, such as: asthma (34 -49 % ), allergic rhinitis (33 -40 % ), and atopic dermatitis (35 -71 % ) ( 42, 43 ) . However, it must be said that the above studies ( 41 -43 ) referred to patients with IgE-mediated food allergy, a condition that -by defi nition -excludes NCWS. In general, the preliminary data that seem to indicate a higher frequency of atopic diseases in NCWS patients and NCWS in atopic patients support the hypothesis that a subgroup of NCWS patients suff er from non-IgE-mediated food allergy.
Histology in NCWS: elements that can support the food allergy hypothesis
Duodenal histology in NCWS patients has been evaluated. Villous atrophy has never been reported, although it is a tautological fi nding because in the presence of villous atrophy NCWS diagnosis is excluded by defi nition ( 4 ). In our experience, there are very few patients who could be included in the diagnostic category of " NCWS plus CM protein hypersensitivity " and who showed mild-to-moderate duodenal villous atrophy (unpublished data). Obviously, we are referring to patients who did not display DQ2 and DQ8 alleles. Owing to the need to explore NCWS while avoiding further confounding elements, we agree that the doubtful cases, that is, those showing intestinal villi damage, must be excluded.
Consequently with HLA-DQ8 -bound gluten peptides; HLA-DQ6 controls did not exhibit the abnormalities in gut function observed in DQ8 mice. Th e authors concluded that gluten sensitivity in HLA-DQ8 mice can induce immune activation in the absence of intestinal atrophy. It could be of interest to connect the above results with our recent data showing an elevated anal sphincter pressure due to wheat and CM -hypersensitivity in patients with anal fi ssures ( 61 ) . In these patients, a wheat-free diet led to a reduction in anal sphincter pressure and a high rate of anal fi ssure healing.
Recently, there was further evidence that HLA-DQ2 / DQ8 -positive patients suff ering from diarrhea-predominant IBS showed higher small bowel and colon permeability on a diet containing gluten than on a diet containing rice. Th ese patients also showed signifi cant decreases in expression of zonula occludens 1, claudin-1, and occludin in rectosigmoid mucosa on the glutencontaining diet. On the whole, these data confi rmed that gluten alters the bowel barrier functions in patients with IBS-diarrhea, particularly in HLA-DQ2 / DQ8 -positive patients ( 62 ) . show clinical laboratory characteristics, which resemble food allergy; this group is, in our experience, the most numerous. Patients on the lower side of the fi gure show no signs of duodenal histology infl ammation and benefi t from a low FODMAP diet -they could not be considered as really affected by NCWS. Patients on the left side of the fi gure are those with " typical IBS " related to psychosomatic mechanisms: in these patients NCWS could be excluded by means of DBPC challenge. The middle of the fi gure underlines the possible role of the microbiota and the change that a restricted diet (i.e., gluten free) can cause in the intestinal fl ora. This could be a key element to understand the effect of the dietary change on intestinal symptoms. Other factors, rarely studied nowadays, should have a role in causing NCWS. AGA, anti-gliadin antibody; BAT, basophil activation test; CD, celiac disease; DBPC, double-blind placebocontrolled; EmA, endomysial antibody; EOS, eosinophils; FODMAP, fermentable oligo-, di-, and mono-saccharides and polyols; IEL, intraepithelial lymphocyte; IgG, immunoglobulin G; NCWS, non-celiac wheat sensitivity.
exclude a CD diagnosis in patients who self-report symptoms related to wheat ingestion. The presence of duodenal villi atrophy cannot be considered mandatory for CD diagnosis, although it is still included in the current diagnostic criteria for adult patients. It has been demonstrated that serum anti-endomysial-positive patients with an initial evaluation of normal duodenal histology had symptom resolution on glutenfree diet, and they eventually developed duodenal villi atrophy on gluten-containing diet ( 51, 52 ) . The objection that these CD patients tested positive for serum CD-specific antibodies (anti-transglutaminase and anti-endomysium), whereas NCWS must be negative by definition, could be disregarded considering that in a very initial phase of CD the specific antibodies can be detected only in the intestinal mucosa, the site of their production, and not in the serum ( 53, 54 ) . Despite the negative serum anti-transglutaminase and anti-endomysium assays and the absence of villous atrophy, we demonstrated that symptomatic patients who produced anti-endomysium in the duodenal culture can subsequently develop villous atrophy when remaining on a gluten-containing diet ( 55 ) . In our recent study, anti-endomysium production in duodenal culture was found in 22 of 276 (8 % ) patients diagnosed with NCWS, thus not showing villi atrophy and positive serum antibodies ( 7 ). It is possible that future diagnostic criteria for CD will include these patients. Other pathogenic mechanisms, even if not immune-mediated, should be considered. For example, it is possible that the non-protein component of wheat might be responsible for symptoms. Th e fermentable fructans could cause IBS-like symptoms ( 6 ) , and it has been demonstrated that fermentable oligo-, di-, and monosaccharides and polyols may cause symptoms, which overlap with IBS ( 56 ) . A wheat-free diet may be useful in these patients, as it reduces the amount of the short-chain carbohydrates present in processed grains and cereals ( 57 ) . Th is hypothesis was recently further supported by a study, which demonstrated that in self-reported NCWS patients the gastrointestinal symptoms signifi cantly improved during reduced fermentable oligo-, di-, and mono-saccharides and polyols intake, but signifi cantly worsened to a similar degree when their diets included gluten or whey protein. Th is study did not show glutenspecifi c gastrointestinal eff ects ( 58 ) . However, it should be noted that the patients included in that study were not representative of NCWS as all subjects with duodenal lymphocitosis (Marsh 1) were excluded and most of the NCWS patients included in other studies showed a Marsh 1 histology. Also the use of whey proteins as placebo could be confounding as we had demonstrated a very high frequency of NCWS associated with CM protein hype rsensitivity ( 7 ) .
A change in diet with wheat withdrawal can also cause a change in the intestinal microbiota. Th is is now considered a crucial element in IBS pathogenesis ( 59 ) . Future studies in NCWS patients should also consider the role of diet in the microbiota and, in turn, on the intestinal immune system. In an animal model, Verd ù et al. ( 60 ) showed that mice sensitized to gliadin displayed intrinsic muscle hypercontractility associated with increased release of acetylcholine from the myenteric plexus. Th is fi nding was associated
In conclusion, NCWS can now be considered the cause of gastrointestinal symptoms, which overlap those commonly attributed to functional disorders. However, many doubts remain and it must be underlined that we must utilize the DBPC challenge method to confi rm the suspicion of NCWS and then study the pathogenesis of that specifi c clinical manifestation. A confi dent NCWS diagnosis must exclude a placebo eff ect. In our opinion, NCWS is a heterogeneous condition, which includes diff erent subgroups of patients ( Figure 1 ). We suggest that the patients suff ering from NCWS alone are probably diff erent from those suff ering from multiple food sensitivity. Th is latter group of patients is more numerous, including a number of cases threefold greater than the patients suff ering from wheat sensitivity alone. Th e patients with NCWS and multiple food sensitivity show several clinical, laboratory, and histology characteristics, which suggest that they might suff er from non-IgE-mediated food allergy. Future studies on the pathogenic mechanisms of this form of NCWS will clarify whether " NCWS " can be replaced by the shorter " wheat hypersensitivity " . 
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